EFFECTS OF ANTIOXIDANTS AND PAF RECEPTOR ANTAGONIST IN INTESTINAL SHOCK IN THE RAT

被引:0
|
作者
HAGLIND, E [1 ]
XIA, GC [1 ]
RYLANDER, R [1 ]
机构
[1] UNIV GOTEBORG, DEPT ENVIRONM MED, GOTHENBURG, SWEDEN
关键词
HYPOVOLEMIA; MUCOSAL LESION; ENDOTOXIN; REPERFUSION; PAF;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In a model of intestinal ischemia-reperfusion resulting in hypotension, mucosal lesions in the small intestine and mortality, the effects of a combination of superoxide dismutase (SOD) and catalase (cat) or a PAF receptor antagonist were tested. Intestinal ischemia was induced in rats and continued for 60 min. After this, the intestine was reperfused. A PAF receptor antagonist, BN 52021, was given 50 min before ischemia in one group, and SOD + cat was given 10 min before reperfusion in one group. One group received normal saline and one group were controls. Blood pressure, mucosal lesions, plasma volume, and endotoxin in plasma were determined up to 3 hr after reperfusion. Mortality was determined over 4 days. Endogenous endotoxin was not found in any of the groups, but the first types of SOD and cat used were contaminated with endotoxin, resulting in exogenous endotoxemia in animals which received those substances. Later endotoxin-free enzymes were used. Neither SOD + cat nor PAF antagonist had any effect on the hypotension or mucosal lesions. Plasma volume remained at the level of the control group after administration of either regimen. Mortality decreased in the group that received SOD + cat. The effects of SOD + cat indicate that free radicals were released in this model at reperfusion, and the effects of the PAF receptor antagonist indicate that PAF participates in membrane damage, but is an intermediary mechanism in the shock model used. The clearance of infused endotoxin from plasma was less effective in the shocked animals, possibly due to a shock effect on reticuloendothelial system (RES). Clinically, the results are interesting in intestinal ischemia-reperfusion. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:83 / 91
页数:9
相关论文
共 50 条
  • [41] EFFECTS OF TCV-309, A NOVEL PAF ANTAGONIST, ON CIRCULATORY SHOCK AND HEMATOLOGICAL ABNORMALITY INDUCED BY ENDOTOXIN IN DOGS
    KAWAMURA, M
    KITAYOSHI, T
    TERASHITA, Z
    FUJIWARA, S
    TAKATANI, M
    NISHIKAWA, K
    JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1994, 9 (03): : 255 - 265
  • [42] PAF-INDUCED AIRWAY RESPONSES IN SHEEP - EFFECTS OF A PAF ANTAGONIST AND NEDOCROMIL SODIUM
    SOLER, M
    MANSOUR, E
    FERNANDEZ, A
    DBROT, J
    AHMED, T
    ABRAHAM, WM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 85 (03) : 661 - 668
  • [43] INHIBITION BY THE PAF ACETHER ANTAGONIST 48740 RP OF THE BRONCHOPULMONARY EFFECTS OF PAF-ACETHER
    DESQUAND, S
    LEFORT, J
    DEREGNAUCOURT, J
    SEDIVY, P
    LAGENTE, V
    RANDON, J
    VARGAFTIG, BB
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1985, 7 (03): : 383 - 383
  • [44] EFFECTS OF CHOLECYSTOKININ RECEPTOR ANTAGONIST LOXIGLUMIDE ON RAT EXOCRINE PANCREAS
    NAKANO, S
    TACHIBANA, I
    OTSUKI, M
    PANCREAS, 1994, 9 (04) : 425 - 433
  • [45] Transcriptional effects of progesterone receptor antagonist in rat granulosa cells
    Friberg, P. Anders
    Larsson, D. G. Joakim
    Billig, Hakan
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 315 (1-2) : 121 - 130
  • [46] THE EFFECTS OF PAF-ACETHER ON THE CARDIOVASCULAR-SYSTEM AND THEIR INHIBITION BY A NEW HIGHLY SPECIFIC PAF-ACETHER RECEPTOR ANTAGONIST BN 52021
    BARANES, J
    HELLEGOUARCH, A
    LEHEGARAT, M
    VIOSSAT, I
    AUGUET, M
    CHABRIER, PE
    BRAQUET, P
    BRAQUET, F
    PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1986, 18 (08): : 717 - 737
  • [47] EFFECT OF THE PAF ANTAGONIST BN-52021 IN OVINE ENDOTOXIN-SHOCK
    REDL, H
    VOGL, C
    SCHIESSER, A
    PAUL, E
    THURNHER, M
    BAHRAMI, S
    SCHLAG, G
    JOURNAL OF LIPID MEDIATORS, 1990, 2 : S195 - S201
  • [48] RP 59227, A NOVEL PAF RECEPTOR ANTAGONIST - EFFECTS IN GUINEA-PIG MODELS OF AIRWAY HYPERREACTIVITY
    UNDERWOOD, SL
    LEWIS, SA
    RAEBURN, D
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 210 (01) : 97 - 102
  • [49] THE ACTIONS OF GR32191B, A THROMBOXANE RECEPTOR ANTAGONIST, ON THE EFFECTS OF INHALED PAF ON HUMAN AIRWAYS
    STENTON, SC
    WARD, C
    DUDDRIDGE, M
    HARRIS, A
    PALMER, JBD
    HENDRICK, DJ
    WALTERS, EH
    CLINICAL AND EXPERIMENTAL ALLERGY, 1990, 20 (03): : 311 - 317
  • [50] ROLE OF PLATELET-ACTIVATING-FACTOR (PAF) IN NEPHROTOXIC NEPHRITIS (NTN) DEMONSTRATED BY A PAF RECEPTOR ANTAGONIST
    LIVIO, M
    MORIGI, M
    ZOJA, C
    REMUZZI, G
    PATRONO, C
    BERTANI, T
    KIDNEY INTERNATIONAL, 1986, 29 (01) : 282 - 282